Back

Manipulation of Bacterial ROS Production Leads to Self-escalating DNA Damage and Resistance-resistant Lethality for Intracellular Mycobacteria

Song, J.; Wang, M.; Tao, H.; Yang, A.; Zhu, Z.; Bai, S.; Luo, M.; Xu, J.; Liu, X.; Sun, Y.; Hu, P.; Wong, W.-L.; Li, F.; Chen, Y.; Cai, Q.; Liu, H.; Huang, S.-Y.; Su, Z.; Feng, X.

2023-07-07 microbiology
10.1101/2023.07.07.548098 bioRxiv
Show abstract

The high prevalence of drug resistance in mycobacteria calls for antimicrobial mechanisms that suppresses the development of resistance. As a structurally conserved multi-site bio-macromolecule, DNA is presumed to be an ideal candidate for such resistance-resistant drug target. However, survey of marketed and investigational DNA interactors indicates that they are not immune to resistance development. Here, we report our strategy to achieve real resistance-resistant DNA targeting by incurring "catastrophic" DNA damage with an organoruthenium-natural product hybrid. The dual-mode DNA damage, in the form of strong tri-valent binding and concomitant oxidative modification, is achieved by manipulating of bacterias native endogenous ROS production mechanism upon lethal stress (such as DNA binding). Such self-escalating DNA damage, together with precise targeting of intracellular bacteria via vacuole fusion, thus endows the hybrids resistance-resistant lethality against mycobacteria and in vivo efficacy in animal models.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

1
Nature Communications
○ 5641 papers in training set
Top 1%
38.6%
Similar papers in this journal
2
Nature
○ 645 papers in training set
Top 2%
9.5%
Similar papers in this journal
3
Cell
○ 431 papers in training set
Top 0.6%
7.7%
Similar papers in this journal
50% of probability mass above
4
Nature Chemical Biology
○ 119 papers in training set
Top 0.4%
5.4%
Similar papers in this journal
5
Proceedings of the National Academy of Sciences
● 2444 papers in training set
Top 13%
4.0%
Similar papers in this journal
6
Science Advances
● 1243 papers in training set
Top 12%
3.1%
7
Nature Microbiology
○ 155 papers in training set
Top 1%
2.6%
8
Nucleic Acids Research
◐ 1281 papers in training set
Top 8%
2.1%
9
Science
● 477 papers in training set
Top 4%
2.1%
10
eLife
● 5828 papers in training set
Top 46%
2.1%
11
Cell Research
○ 51 papers in training set
Top 0.4%
2.1%
12
Nature Chemistry
○ 42 papers in training set
Top 0.4%
1.9%
13
ACS Central Science
● 71 papers in training set
Top 1%
1.1%
14
Cell Reports
○ 1498 papers in training set
Top 24%
1.0%
15
Nature Structural & Molecular Biology
236 papers in training set
Top 3%
1.0%
16
Nature Ecology & Evolution
131 papers in training set
Top 2%
1.0%
17
Chemical Science
● 73 papers in training set
Top 2%
0.8%
18
Nature Medicine
○ 125 papers in training set
Top 4%
0.8%
19
Signal Transduction and Targeted Therapy
○ 30 papers in training set
Top 0.7%
0.8%
20
Advanced Science
○ 286 papers in training set
Top 10%
0.8%
21
The EMBO Journal
○ 309 papers in training set
Top 8%
0.6%
22
Cell Chemical Biology
○ 94 papers in training set
Top 2%
0.6%
23
Communications Biology
○ 993 papers in training set
Top 36%
0.6%
24
ACS Nano
● 113 papers in training set
Top 2%
0.6%
25
Cell Reports Medicine
○ 153 papers in training set
Top 6%
0.6%

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.